Brokerage Firm Rating Update on Wright Medical Group (WMGI)

Wright Medical Group (WMGI) : Zacks Investment Research ranks Wright Medical Group (WMGI) as 3, which is a Hold recommendation. 12 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. 2 other analysts are mildly bullish on the stock and favor a Buy. A total of 2 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 16 research analysts is 1.38, which indicates as a Strong Buy.

Wright Medical Group (WMGI) : The highest level Wright Medical Group (WMGI) is projected to reach is $33 for the short term and the lowest estimate is at $23. The consolidated price target from 10 rating analysts who initiate coverage on the stock is $27.2 and the possibility the share price can swing is $2.97.


For the current week, the company shares have a recommendation consensus of Buy. Also, Brokerage firm UBS maintains its rating on Wright Medical Group (NASDAQ:WMGI). As per the latest information, the brokerage house lowers the price target to $28 per share from a prior target of $30. The shares have been rated Buy. The rating by the firm was issued on August 3, 2016.

Wright Medical Group (NASDAQ:WMGI): stock was range-bound between the intraday low of $24.57 and the intraday high of $24.9 after having opened at $24.69 on Wednesdays session. The stock finally closed in the red at $24.69, a loss of -0.36%. The stock remained in the red for the whole trading day. The total traded volume was 574,517 shares. The stock failed to cross $24.9 in Wednesdays trading. The stocks closing price on Thursday was $24.7.

Wright Medical Group, Inc. is a global specialty orthopaedic company. The Company through Wright Medical Technology, Inc. (WMT) and other subsidiaries provides extremity and biologic solutions that enable clinicians to alleviate pain and restore the patients lifestyles. The Company operates through three segments: U.S., International and BioMimetic. The Companys business includes products that are used in foot and ankle repair, upper extremity products and biologics products, which are used to replace damaged or diseased bone, to stimulate bone growth and to provide other biological solutions for surgeons and patients. The Companys products include extremity hardware, foot and ankle hardware, upper extremity hardware and biologics.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.